1.
Likhar RV, Joshi S. Recent development of heterocyclic scaffolds as EGFR kinase inhibitors in cancer. Curr. Issues Pharm. Med. Sci. [Internet]. 2025 May 21 [cited 2026 Feb. 10];38(2):112-21. Available from: https://czasopisma.umlub.pl/curipms/article/view/2935